also demonstrated that cisplatin suppresses SIRT3 in CRC cells, resulting in hyperacetylation and inactivation of the key enzyme MTHFD2, which is involved in mitochondrial folate metabolism (214). Here, SIRT3 is linked to colorectal carcinoma.